532089 Sigma-AldrichDual DYRK/CLK inhibitor, Cpd 23 - Calbiochem
Synonymes: Pre-mRNA Splicing Modulator, DYRK Inhibitor, Cdc2-like Kinase Inhibitor
Produits recommandés
Aperçu
Replacement Information |
---|
Tableau de caractéristiques principal
Empirical Formula |
---|
C₁₀H₈O₂S |
References | |
---|---|
References | Schmitt, C., et al. 2014. ACS Med. Chem. Lett. 5, 963. |
Product Information | |
---|---|
Form | Yellow powder |
Hill Formula | C₁₀H₈O₂S |
Chemical formula | C₁₀H₈O₂S |
Reversible | Y |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | DYRK/CLK |
Primary Target IC<sub>50</sub> | 60 nM, EC₅₀ |
Purity | ≥95% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Référence | GTIN |
532089 | 0 |
Documentation
Dual DYRK/CLK inhibitor, Cpd 23 - Calbiochem FDS
Titre |
---|
Références bibliographiques
Aperçu de la référence bibliographique |
---|
Schmitt, C., et al. 2014. ACS Med. Chem. Lett. 5, 963. |
Informations techniques
Titre |
---|
Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System |
White Paper: Further considerations of antibody validation and usage. |